Arcadia Biosciences Files 2024 Annual Report Amendment
Ticker: RKDA · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, filing-update
TL;DR
Arcadia Biosciences filed its 2024 10-K amendment, check for updates.
AI Summary
Arcadia Biosciences, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on April 30, 2025, provides updated information for the period. The company is incorporated in Delaware and its principal executive offices are located in Dallas, Texas.
Why It Matters
This amendment to the annual report provides updated financial and operational information for Arcadia Biosciences, Inc., which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — As an amendment to an annual report, it signifies potential revisions or additions to previously disclosed information, which could indicate underlying issues or changes in the company's financial health.
Key Numbers
- 001-37383 — SEC File Number (Identifies the specific SEC filing for Arcadia Biosciences, Inc.)
- 81-0571538 — EIN (Employer Identification Number for Arcadia Biosciences, Inc.)
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Dallas, TX (location) — Principal executive offices
- December 31, 2024 (date) — Fiscal year end
- April 30, 2025 (date) — Filing date
FAQ
What specific information was amended in the 10-K filing?
The filing is an amendment (10-K/A) to the annual report for the fiscal year ended December 31, 2024, indicating that specific sections or disclosures from the original 10-K filing have been revised or supplemented.
When was the original 10-K filed, and what is the purpose of this amendment?
The original 10-K was for the fiscal year ended December 31, 2024. This amendment, filed on April 30, 2025, serves to correct or add information to the original filing.
Where are Arcadia Biosciences, Inc.'s principal executive offices located?
Arcadia Biosciences, Inc.'s principal executive offices are located at 5950 Sherry Lane, Suite 215, Dallas, TX 75225.
What is the company's state of incorporation?
Arcadia Biosciences, Inc. is incorporated in Delaware.
What is the SEC file number for Arcadia Biosciences, Inc.?
The SEC file number for Arcadia Biosciences, Inc. is 001-37383.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding Arcadia Biosciences, Inc. (RKDA).